Neonatal perspective on central lymphatic disorders

Semin Pediatr Surg. 2024 Jun;33(3):151424. doi: 10.1016/j.sempedsurg.2024.151424. Epub 2024 May 22.

Abstract

Lymphatic disorders presenting in the first year of life are difficult to identify and manage given the broad range of underlying etiologies. Neonatal lymphatic disease arising from congenital or acquired conditions results in the abnormal accumulation of lymph fluid in the pleura (chylothorax), peritoneum (chylous ascites) and skin (edema/anasarca). There is also increasing recognition of lymphatic losses through the intestine resulting in protein-losing enteropathy (PLE). While the incidence of lymphatic disorders in neonates is unclear, advances in genetic testing and lymphatic imaging are improving our understanding of the underlying pathophysiology. Despite these advancements, medical management of neonatal lymphatic disorders remains challenging and variable among clinicians.

Publication types

  • Review

MeSH terms

  • Chylothorax / diagnosis
  • Chylothorax / etiology
  • Chylothorax / therapy
  • Humans
  • Infant, Newborn
  • Lymphatic Diseases* / diagnosis
  • Lymphatic Diseases* / etiology
  • Lymphatic Diseases* / therapy
  • Lymphedema / diagnosis
  • Lymphedema / etiology
  • Lymphedema / therapy
  • Protein-Losing Enteropathies / diagnosis
  • Protein-Losing Enteropathies / etiology
  • Protein-Losing Enteropathies / therapy